June 13 (Reuters) - Aequus Pharmaceuticals Inc AQS.V -
* Has entered into an exclusive agreement in Canada with a unit of Santen Pharmaceutical
* Under agreement, Aequus and Santen will plan to co-commercialize an undisclosed ophthalmology therapeutic product
* Aequus Pharmaceuticals - as per agreement, santen will be responsible for product manufacturing, distribution, co will be responsible for field activities
* Net product revenues will be split between aequus and santen over a ten-year term Source text for Eikon: ID:nMKWyPXFga Further company coverage: AQS.V